To study the effect of homoeopathic medicines in the management of ovarian cysts.
Phase 3
- Conditions
- Health Condition 1: D279- Benign neoplasm of unspecified ovaryHealth Condition 2: N801- Endometriosis of ovary
- Registration Number
- CTRI/2022/03/040879
- Lead Sponsor
- Dr Prem Deeshna Pritam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Women between 15-75 years of age.
2)Diagnosed as benign pathological ovarian mass on ultrasonography of pelvis.
Exclusion Criteria
1) Malignant ovarian masses.
2) Raised CA 125 levels except for endometriotic cysts/ endometriomas
3) Ovarian masses with complications (intra-cystic or intra-abdominal hemorrhage, torsion, infection, rupture)
4) Pregnant mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) To determine the effectiveness of Homoeopathic medicines in reducing the size of benign pathological ovarian masses.Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method 1) To find out the effectiveness of homoeopathic medicines in complete resolution of the benign pathological ovarian masses. <br/ ><br>2) To find out the effectiveness of homoeopathic medicines in reducing dysmenorrhea in cases diagnosed with benign pathological ovarian masses. <br/ ><br>3) To find out the effectiveness of homoeopathic medicines in reducing the abnormal uterine bleeding in cases diagnosed with benign pathological ovarian masses. <br/ ><br>Timepoint: 1 year